Skip to content

Cardiovascular Patients With no Standard Modifiable Risk Factors

Absence of Standard Modifiable Risk Factors Among 5000 Middle Eastern Patients With Atherosclerotic Cardiovascular Disease: Clinical Profiles and Prevalence of Other Risk Factors and Comorbidities

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06199869
Acronym
SMuRF-less-ME1
Enrollment
5540
Registered
2024-01-10
Start date
2024-01-22
Completion date
2025-01-31
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Risk Factors

Keywords

Atherosclerotic cardiovascular disease, Standard modifiable risk factors (SMuRFs), Middle Eastern population

Brief summary

A growing number of patients develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of standard modifiable risk factors (SMuRF-less). There is scarcity of studies that address this issue in the Middle Eastern population.

Detailed description

Atherosclerotic coronary artery disease (ASCAD) claims millions of lives annually on a global level and is the leading cause of death in the Middle East. There are four standard modifiable cardiovascular risk factors (SMuRFs): hypertension, type 2 diabetes mellitus, dyslipidemia, and smoking. These are very common in the Middle East and are crucial to be screened for and addressed in an affective manner. However, an increasing proportion of patients with ASCVD have none of these individual factors (SMuRF-less). Globally, this proportion comprises 11.6% of individuals with stable coronary disease and heart attack. No prior study has addressed the issue of the prevalence of SMuRF-less patients among the whole population of individuals with ASCVD in the Middle East.

Interventions

OTHEREvaluation of risk factors by direct interview with subjects who have atherosclerotic cardiovascular patients

Individuals identified with a diagnosis of ASCVD will fill a one page form of the associated risk factors they have

Sponsors

The Jordan Cardiovascular Research Group JoCVRG
CollaboratorOTHER
Yarmouk University School of Medicine
CollaboratorUNKNOWN
Jordan Collaborating Cardiology Group
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* A diagnosis of atherosclerotic cardiovascular disease (ASCVD). * Ability to fill the clinical form that evaluates the presence or absence of cardiovascular risk factors including the 4 SMuRFs.

Exclusion criteria

* Atherosclerotic cardiovascular disease diagnosed before the age of 18 years. * Inability to give detailed history of prespecified risk factors.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of patients who do not any of the four SMuRFsUp to 4 weeks after study enrollmentGroup of patients with definite ASCVD who do not have hypertension, diabetes, dyslipidemia or smoking.

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026